Our businesses fall into three main groups at Medtronic:
- Cardiac and Vascular Group (CVG): $8.7 Billion
- Restorative Therapies Group (RTG): $6.4 Billion
- Diabetes Group (DG): $1.5 Billion
FY2013 Revenue by Business (in millions) - Enlarge Chart
Cardiac and Vascular Group
Our Cardiac and Vascular Group (CVG) brings all Medtronic cardiac and vascular businesses together into one cross-functional, collaborative operating unit. CVG provides innovative and comprehensive solutions that extend beyond the industry’s broadest portfolio of technologies to programs and services that drive economic value across the care continuum.
Restorative Therapies Group
The Restorative Therapies Group (RTG) provides innovative, life changing restorative therapies and services to meet the needs of millions of people worldwide who suffer from a wide range of chronic medical conditions.
The Diabetes Group (DG) at Medtronic is the world leader in advanced diabetes management solutions, including integrated diabetes management systems, insulin pump therapy, continuous glucose monitoring systems and therapy management software, as well as world-class, 24/7 expert consumer and professional service and support.